6,000-Patient study seeks to unlock secrets of bile duct disease
NCT ID NCT06881004
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will enroll 6,000 people with bile duct widening (choledochal cyst) from 25 hospitals in China. Researchers will track patients over time to better understand the condition, including how it progresses, cancer risks, and the best timing for surgery. The goal is to create a standard classification and treatment plan for different types of this disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better surgical guidelines and clearer understanding of cancer risk for people with bile duct widening.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly change patient care, and results depend on data quality from many hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLEDOCHAL CYST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tsinghua Chang Gung Hospital
RECRUITINGBeijing, Beijing Municipality, 102218, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.